Advertisement

ResearchIn-Press PreviewImmunology Free access | 10.1172/JCI128895

CD73 Immune Checkpoint Defines Regulatory NK-cells within the Tumor Microenvironment

Shi Yong Neo, Ying Yang, Record Julien, Ran Ma, Xinsong Chen, Ziqing Chen, Nicholas P. Tobin, Emily Blake, Christina Seitz, Ron Thomas, Arnika Kathleen Wagner, John Andersson, Jana de Boniface, Jonas Bergh, Shannon Murray, Evren Alici, Richard Childs, Martin Johansson, Lisa S. Westerberg, Felix Haglund, Johan Hartman, and Andreas Lundqvist

Find articles by Neo, S. in: JCI | PubMed | Google Scholar

Find articles by Yang, Y. in: JCI | PubMed | Google Scholar

Find articles by Julien, R. in: JCI | PubMed | Google Scholar |

Find articles by Ma, R. in: JCI | PubMed | Google Scholar

Find articles by Chen, X. in: JCI | PubMed | Google Scholar

Find articles by Chen, Z. in: JCI | PubMed | Google Scholar

Find articles by Tobin, N. in: JCI | PubMed | Google Scholar

Find articles by Blake, E. in: JCI | PubMed | Google Scholar |

Find articles by Seitz, C. in: JCI | PubMed | Google Scholar

Find articles by Thomas, R. in: JCI | PubMed | Google Scholar

Find articles by Wagner, A. in: JCI | PubMed | Google Scholar

Find articles by Andersson, J. in: JCI | PubMed | Google Scholar

Find articles by de Boniface, J. in: JCI | PubMed | Google Scholar |

Find articles by Bergh, J. in: JCI | PubMed | Google Scholar

Find articles by Murray, S. in: JCI | PubMed | Google Scholar

Find articles by Alici, E. in: JCI | PubMed | Google Scholar

Find articles by Childs, R. in: JCI | PubMed | Google Scholar

Find articles by Johansson, M. in: JCI | PubMed | Google Scholar

Find articles by Westerberg, L. in: JCI | PubMed | Google Scholar

Find articles by Haglund, F. in: JCI | PubMed | Google Scholar |

Find articles by Hartman, J. in: JCI | PubMed | Google Scholar |

Find articles by Lundqvist, A. in: JCI | PubMed | Google Scholar

First published November 26, 2019 - More info

J Clin Invest. https://doi.org/10.1172/JCI128895.
Copyright © 2019, American Society for Clinical Investigation
First published November 26, 2019 - Version history
Abstract

High levels of ecto-5'-nucleotidase (CD73) have been implicated in immune suppression and tumor progression, and have also been observed in cancer patients who progress on anti-PD-1 immunotherapy. While regulatory T cells can express CD73 and inhibit T cell responses via the production of adenosine, less is known about CD73 expression in other immune cell populations. We found that tumor-infiltrating NK cells upregulate CD73 expression and the frequency of these CD73+ NK cells correlated with larger tumor size in breast cancer patients. In addition, the expression of multiple alternative immune checkpoint receptors including LAG-3, VISTA, PD-1, and PD-L1 was significantly higher in CD73 positive NK cells than in CD73 negative NK cells. Mechanistically, NK cells transport CD73 in intracellular vesicles to the cell surface and the extracellular space via actin polymerization-dependent exocytosis upon engagement of 4-1BBL on tumor cells. These CD73 positive NK cells undergo transcriptional reprogramming and upregulate IL10 production via STAT3 transcriptional activity, suppressing CD4 T cell proliferation and IFN-ɣ production. Taken together, our results support that tumors can hijack NK cells as a means to escape immunity and that CD73 expression defines an inducible population of NK cells with immune regulatory properties within the tumor microenvironment. 

Graphical Abstract
graphical abstract
Supplemental material

View supplementary table 1

View supplementary table 3

View supplementary table 2

View

Version history
  • Version 1 (November 26, 2019): In-Press Preview
Advertisement
Advertisement